查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1396946

深奧的測試市場：按類型、技術和最終用戶分類：2023-2032 年全球機會分析和產業預測

Esoteric Testing Market By Type, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 307 Pages | 商品交期: 2-3個工作天內

價格

2022 年深奧測試市場價值為 242 億美元，預計到 2032 年將達到 685 億美元，2023 年至 2032 年的年複合成長率為 11.0%。

深奧測試被定義為對常規臨床實驗室中未進行的稀有分子的分析。該分析使用多種技術進行，包括即時聚合酶鍊式反應、酵素結合免疫吸附測定、流式細胞儀和 DNA定序。這些測試需要特殊設備並且是小規模進行的。需要熟練的人員使用各種化學品和精密設備來執行這些測試並分析結果。深奧的檢驗通常用於診斷罕見疾病、感染疾病和內分泌疾病。

癌症、高血壓、糖尿病、慢性感染疾病等慢性疾病的盛行率不斷上升，人們對早期疾病診斷重要性的認知不斷提高，以及新測試的不斷推出，顯著推動了深奧檢測市場的成長。深奧的測試旨在檢測特定標記物，以便更準確地診斷和預測癌症和愛滋病毒等慢性疾病。例如，根據美國癌症協會 (ACS) 的數據，預計 2022 年美國將診斷出約 190 萬例新癌症病例。因此，慢性病盛行率的增加推動了對專門且困難的測試的需求。

此外，大眾對疾病早期診斷的認知不斷提高，也增加了對困難檢測的需求。宣傳宣傳活動、教育研討會和培訓計劃強調早期疾病診斷的重要性。例如，羅氏公司（F. Hoffmann-La Roche Ltd.）與社區合作夥伴合作，針對癌症、肝炎、結核病、HIV、HPV、心血管疾病和糖尿病等疾病實施篩檢和諮詢項目。我支持。此外，技術進步和新產品的推出進一步推動了市場成長。例如，全球生命科學公司美國實驗室控股公司推出了一種新的神經絲輕鏈（NfL）血液檢測，可提供神經神經退化和神經元細胞損傷的直接證據。該測試使醫生能夠識別和確認神經退化性疾病的跡象。

然而，與深奧測試相關的高成本和熟練實驗室技術人員的短缺預計將阻礙預測期內的市場成長。另一方面，預計診斷測試數量的增加和 DNA定序技術的進步將為預測期內的市場成長創造利潤豐厚的機會。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 慢性疾病和感染疾病增加
      • 提高早期疾病診斷和個人化醫療的意識
      • 醫療檢測機構數量增加
    • 抑制因素
      • 測試難度高成本
    • 機會
      • 深奧測試的技術進步

第 4 章 深奧測驗市場：按類型

  • 概述
  • 傳染病檢查
  • 腫瘤檢查
  • 內分泌檢查
  • 基因檢測
  • 毒理學測試
  • 免疫學測試
  • 神經學檢查
  • 其他測試

第5章深奧的測試市場：依技術分類

  • 概述
  • 酵素結合免疫吸附檢測法
  • 化學冷光免疫檢測
  • 質譜
  • 即時聚合酶鍊式反應
  • 脫氧核糖核酸序列
  • 流式細胞儀
  • 其他技術

第 6 章 深奧的測試市場：按最終用戶

  • 概述
  • 醫院實驗室
  • 獨立測試機構/參考測試機構

第7章深奧測試市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • Laboratory Corporation of America Holdings
  • ARUP Laboratories
  • Mayo Foundation for Medical Education and Research
  • Healius Limited
  • Opko Health, Inc.
  • Quest Diagnostics Inc.
  • Sonic Healthcare Limited
  • F. Hoffmann-La Roche Ltd.
  • Stanford Health Care
  • Athena Esoterix, LLC.
Product Code: A12022

The esoteric testing market was valued at $24.2 billion in 2022 and is estimated to reach $68.5 billion by 2032, exhibiting a CAGR of 11.0% from 2023 to 2032. Esoteric testing is defined as the analysis of rare molecules that are not performed in routine clinical labs. This analysis is done by using various technologies such as real time polymerase chain reaction, enzyme linked immunosorbent assay, flow cytometry, and DNA sequencing. These tests require specialized equipment and are performed on a small scale. It requires skilled personnel to conduct these tests and analyze the result by using various chemical agents and sophisticated instruments. Esoteric testing is generally performed for the diagnosis of rare diseases, infectious diseases, and endocrine diseases.

The esoteric testing market growth is significantly driven by increase in the prevalence of chronic diseases such as cancer, hypertension, diabetes and chronic infectious diseases; surge in awareness about importance of early disease diagnosis; and increase in new test launches. Esoteric tests are designed to detect specific markers to enable more precise diagnosis and prognosis of chronic diseases such as cancer and HIV. For instance, according to American Cancer Society (ACS), about 1.9 million new cancer cases are expected to be diagnosed in the U.S. in 2022. Thus, rise in prevalence of chronic diseases drives the demand for specialized, esoteric tests.

Furthermore, surge in awareness about early disease diagnosis among the general population has increased the demand for esoteric testing. Awareness campaigns, educational seminars, and training programs emphasize the importance of early disease diagnosis. For instance, F. Hoffmann-La Roche Ltd., supports local community partners to run screening programs and counselling programs for diseases such as cancers, hepatitis, tuberculosis, HIV, HPV, cardiovascular disease and diabetes. Moreover, technological advancements and new product launches further drive the market growth. For instance, Laboratory Corporation of America Holdings, a global life sciences company, launched its new Neurofilament Light Chain (NfL) blood test that provides direct evidence of neurodegeneration and neuronal injury. This test will allow doctors to identify and verify signs of neurodegenerative diseases.

However, the high cost associated with esoteric testing and lack of skilled laboratory technicians are anticipated to hinder the market growth during the forecast period. On the other hand, increase in the number of diagnostic testing and technological advancements in DNA sequencing are expected to create lucrative opportunities for market growth during the forecast period.

The esoteric testing market is segmented into type, technology, end user, and region. By type, the market is categorized into infectious disease testing, oncology testing, endocrinology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing. By technology, the market is divided into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, mass-spectrometry, real time polymerase chain reaction, DNA sequencing, flow cytometry, and other technologies. By end user, the market is bifurcated into hospital-based laboratories and independent & reference laboratories. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global esoteric testing market are Laboratory Corporation of America Holdings, ARUP Laboratories, Opko Health, Inc., Quest Diagnostics Inc., F. Hoffmann-La Roche Ltd., Mayo Foundation for Medical Education and Research, Stanford Health Care, Healius Limited, Athena Esoterix, LLC, and Sonic Healthcare Limited. Key players operating in the market have adopted product launch, collaboration, and product approval as key strategies to expand their market share and product portfolio.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the esoteric testing market analysis from 2022 to 2032 to identify the prevailing esoteric testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the esoteric testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global esoteric testing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Infectious Disease Testing
  • Oncology Testing
  • Endocrinology Testing
  • Genetic Testing
  • Toxicology Testing
  • Immunology Testing
  • Neurology Testing
  • Other Testings

By Technology

  • Enzyme-linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Mass Spectrometry
  • Real Time Polymerase Chain Reaction
  • DNA Sequencing
  • Flow Cytometry
  • Other Technologies

By End User

  • Hospital-based Laboratories
  • Independent and Reference Laboratories

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • ARUP Laboratories
    • Quest Diagnostics Inc.
    • F. Hoffmann-La Roche Ltd.
    • Stanford Health Care
    • Healius Limited
    • Laboratory Corporation of America Holdings
    • Opko Health, Inc.
    • Mayo Foundation for Medical Education and Research
    • Athena Esoterix, LLC.
    • Sonic Healthcare Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of chronic and infectious diseases
      • 3.4.1.2. Increase in awareness about early disease diagnosis and personalized medicine
      • 3.4.1.3. Increase in number of medical laboratories
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of esoteric testing
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancements in esoteric testing

CHAPTER 4: ESOTERIC TESTING MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Infectious Disease Testing
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Oncology Testing
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Endocrinology Testing
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Genetic Testing
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Toxicology Testing
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country
  • 4.7. Immunology Testing
    • 4.7.1. Key market trends, growth factors and opportunities
    • 4.7.2. Market size and forecast, by region
    • 4.7.3. Market share analysis by country
  • 4.8. Neurology Testing
    • 4.8.1. Key market trends, growth factors and opportunities
    • 4.8.2. Market size and forecast, by region
    • 4.8.3. Market share analysis by country
  • 4.9. Other Testings
    • 4.9.1. Key market trends, growth factors and opportunities
    • 4.9.2. Market size and forecast, by region
    • 4.9.3. Market share analysis by country

CHAPTER 5: ESOTERIC TESTING MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Enzyme-linked Immunosorbent Assay
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Chemiluminescence Immunoassay
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Mass Spectrometry
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Real Time Polymerase Chain Reaction
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. DNA Sequencing
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country
  • 5.7. Flow Cytometry
    • 5.7.1. Key market trends, growth factors and opportunities
    • 5.7.2. Market size and forecast, by region
    • 5.7.3. Market share analysis by country
  • 5.8. Other Technologies
    • 5.8.1. Key market trends, growth factors and opportunities
    • 5.8.2. Market size and forecast, by region
    • 5.8.3. Market share analysis by country

CHAPTER 6: ESOTERIC TESTING MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospital-based Laboratories
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Independent and Reference Laboratories
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: ESOTERIC TESTING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Technology
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Technology
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Technology
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Technology
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Technology
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Technology
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Technology
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Technology
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Technology
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Technology
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Technology
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Technology
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Technology
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Technology
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Technology
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Technology
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. Rest of Asia-Pacific
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Technology
      • 7.4.5.5.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Technology
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Technology
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Technology
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Technology
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Technology
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Laboratory Corporation of America Holdings
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. ARUP Laboratories
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. Mayo Foundation for Medical Education and Research
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Healius Limited
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Opko Health, Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Quest Diagnostics Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Sonic Healthcare Limited
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. F. Hoffmann-La Roche Ltd.
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Stanford Health Care
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Athena Esoterix, LLC.
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. ESOTERIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. ESOTERIC TESTING MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. ESOTERIC TESTING MARKET FOR ENDOCRINOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. ESOTERIC TESTING MARKET FOR GENETIC TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. ESOTERIC TESTING MARKET FOR TOXICOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. ESOTERIC TESTING MARKET FOR IMMUNOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. ESOTERIC TESTING MARKET FOR NEUROLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. ESOTERIC TESTING MARKET FOR OTHER TESTINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 11. ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. ESOTERIC TESTING MARKET FOR MASS SPECTROMETRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. ESOTERIC TESTING MARKET FOR REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. ESOTERIC TESTING MARKET FOR DNA SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. ESOTERIC TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 26. U.S. ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. U.S. ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 28. U.S. ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. CANADA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. CANADA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 31. CANADA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. GERMANY ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. UK ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. UK ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 47. UK ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. ITALY ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. ITALY ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 50. ITALY ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. SPAIN ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 53. SPAIN ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 55. REST OF EUROPE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 56. REST OF EUROPE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 59. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 60. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 61. JAPAN ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. JAPAN ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. CHINA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 65. CHINA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 66. CHINA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. INDIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. INDIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 69. INDIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. AUSTRALIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. AUSTRALIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 75. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 78. LAMEA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. LAMEA ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 80. BRAZIL ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 81. BRAZIL ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 82. BRAZIL ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. SAUDI ARABIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 85. SAUDI ARABIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH AFRICA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH AFRICA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 90. REST OF LAMEA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 91. REST OF LAMEA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES
  • TABLE 93. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
  • TABLE 94. LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT SEGMENTS
  • TABLE 95. LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 96. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY STRATERGIES
  • TABLE 97. ARUP LABORATORIES: KEY EXECUTIVES
  • TABLE 98. ARUP LABORATORIES: COMPANY SNAPSHOT
  • TABLE 99. ARUP LABORATORIES: SERVICE SEGMENTS
  • TABLE 100. ARUP LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 101. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: KEY EXECUTIVES
  • TABLE 102. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: COMPANY SNAPSHOT
  • TABLE 103. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: SERVICE SEGMENTS
  • TABLE 104. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: PRODUCT PORTFOLIO
  • TABLE 105. HEALIUS LIMITED: KEY EXECUTIVES
  • TABLE 106. HEALIUS LIMITED: COMPANY SNAPSHOT
  • TABLE 107. HEALIUS LIMITED: SERVICE SEGMENTS
  • TABLE 108. HEALIUS LIMITED: PRODUCT PORTFOLIO
  • TABLE 109. OPKO HEALTH, INC.: KEY EXECUTIVES
  • TABLE 110. OPKO HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 111. OPKO HEALTH, INC.: PRODUCT SEGMENTS
  • TABLE 112. OPKO HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 113. OPKO HEALTH, INC.: KEY STRATERGIES
  • TABLE 114. QUEST DIAGNOSTICS INC.: KEY EXECUTIVES
  • TABLE 115. QUEST DIAGNOSTICS INC.: COMPANY SNAPSHOT
  • TABLE 116. QUEST DIAGNOSTICS INC.: SERVICE SEGMENTS
  • TABLE 117. QUEST DIAGNOSTICS INC.: PRODUCT PORTFOLIO
  • TABLE 118. QUEST DIAGNOSTICS INC.: KEY STRATERGIES
  • TABLE 119. SONIC HEALTHCARE LIMITED: KEY EXECUTIVES
  • TABLE 120. SONIC HEALTHCARE LIMITED: COMPANY SNAPSHOT
  • TABLE 121. SONIC HEALTHCARE LIMITED: SERVICE SEGMENTS
  • TABLE 122. SONIC HEALTHCARE LIMITED: PRODUCT PORTFOLIO
  • TABLE 123. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 124. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 125. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
  • TABLE 126. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 127. STANFORD HEALTH CARE: KEY EXECUTIVES
  • TABLE 128. STANFORD HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 129. STANFORD HEALTH CARE: SERVICE SEGMENTS
  • TABLE 130. STANFORD HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 131. ATHENA ESOTERIX, LLC.: KEY EXECUTIVES
  • TABLE 132. ATHENA ESOTERIX, LLC.: COMPANY SNAPSHOT
  • TABLE 133. ATHENA ESOTERIX, LLC.: SERVICE SEGMENTS
  • TABLE 134. ATHENA ESOTERIX, LLC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. ESOTERIC TESTING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ESOTERIC TESTING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN ESOTERIC TESTING MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN ESOTERIC TESTING MARKET (2023-2032)
  • FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL ESOTERIC TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. ESOTERIC TESTING MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ONCOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ENDOCRINOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR GENETIC TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR TOXICOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR IMMUNOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR NEUROLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR OTHER TESTINGS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR MASS SPECTROMETRY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR REAL TIME POLYMERASE CHAIN REACTION, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR DNA SEQUENCING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 28. ESOTERIC TESTING MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 30. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 31. ESOTERIC TESTING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 32. U.S. ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. CANADA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. MEXICO ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. GERMANY ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. FRANCE ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. UK ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. ITALY ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SPAIN ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF EUROPE ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. JAPAN ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. CHINA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. INDIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. AUSTRALIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. BRAZIL ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. SAUDI ARABIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. SOUTH AFRICA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. REST OF LAMEA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: ESOTERIC TESTING MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2022
  • FIGURE 57. LABORATORY CORPORATION OF AMERICA HOLDINGS: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. HEALIUS LIMITED: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 60. HEALIUS LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. OPKO HEALTH, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. OPKO HEALTH, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. QUEST DIAGNOSTICS INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 64. QUEST DIAGNOSTICS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. SONIC HEALTHCARE LIMITED: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 66. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 67. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 68. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 69. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. STANFORD HEALTH CARE: NET REVENUE, 2020-2022 ($MILLION)